
    
      In order to assess the mid term effects of beta-glucans on lipid profile, glycemia and
      intestinal function, moderately hypercholesterolemic subjects will be involved in a
      cross-over study and supplemented for 8 weeks with 3 g/day of beta-glucans or placebo. The
      two intervention periods will be spaced by a 4 week washout period
    
  